Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study.
Ken H. Young(Duke Medical Center), Lin Wu(Materials Systems (United States)), Suzanne M. Selvaggi(University of Wisconsin–Madison), Karen Dybkær(Aalborg University Hospital), Kristin E. Hunt(University of New Mexico), Weina Chen(Army Medical University), James S. Malter(The University of Texas Southwestern Medical Center), Govind Bhagat(Columbia University Irving Medical Center), Stacey S. O’Neill(University of North Carolina at Chapel Hill), Matthew Twohig(University of Wisconsin–Madison), Eric D. Hsi(Mayo Clinic), Nancy Patten(Materials Systems (United States)), Ronald S. Go(Mayo Clinic), Kazunori Kanehira(Kyoto University Hospital), Attilio Orazi(Texas Tech University), Sim Truong(Materials Systems (United States)), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Jeff Chang(Methodist Hospital), Magdalena Czader(Karolinska Institutet), Gabrielle L. Rocque(University of Wisconsin–Madison), Jeffrey Malik(University of Wisconsin–Madison), April Chiu(Mayo Clinic), William M. Rehrauer(University of Wisconsin–Madison), Brad S. Kahl(UW Health University Hospital), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Santiago Montes‐Moreno(Universidad de Cantabria), Michelle Waknitz(University of Wisconsin–Madison), Huan‐You Wang(University of California San Diego), Jens C. Eickhoff(University of Wisconsin–Madison), Yong Li(Baylor College of Medicine), Yan Li(University of Louisville), Fan Zhou(Southwest Washington Medical Center), Xianfeng Zhao(University of Maryland, Baltimore), William W.L. Choi(Chinese University of Hong Kong), Jane N. Winter(Northwestern University), Cherie H. Dunphy(Saint Louis University), Michael Møller(Hospital South West Jutland)
Cited by 1
Related Papers
Embryonic Stem Cell Lines Derived from Human Blastocysts
|Science|1998|15.9k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k